Related Experiment Videos
Systemic inflammatory mediators and cystic fibrosis genotype
A Augarten1, G Paret, I Avneri
1National CF Center, The Chaim Sheba Medical Center, Tel-Hashomer, Israel 52621. augarten@post.tau.ac.il
Clinical and Experimental Medicine
|January 28, 2005
Summary
Elevated interleukin-8 serum levels in cystic fibrosis patients correlate with severe genotypes and reduced lung function. This suggests interleukin-8 may indicate early inflammation, prompting anti-inflammatory treatment.
Area of Science:
- Pulmonary Medicine
- Immunology
- Genetics
Background:
- Cystic fibrosis (CF) morbidity and mortality are primarily driven by pulmonary infection and inflammation.
- Chemokines are key mediators in the inflammatory process within the lungs.
- The precise link between cystic fibrosis transmembrane regulator (CFTR) gene mutations and pulmonary inflammation requires further elucidation.
Purpose of the Study:
- To investigate the correlation between serum chemokine levels (interleukin-8, RANTES, monocyte chemoattractant protein-1) and CFTR genotype in cystic fibrosis patients.
- To assess associations between chemokine levels, pulmonary function tests, and other clinical characteristics.
- To determine if serum chemokine levels can serve as biomarkers for disease severity and inflammation.
Main Methods:
- Serum samples were collected from 36 cystic fibrosis patients, categorized into two groups based on genotype severity.
- Group A comprised 25 patients with severe CFTR mutations; Group B included 11 patients with milder CFTR mutations.
- Levels of interleukin-8, RANTES, and monocyte chemoattractant protein-1 were quantified and correlated with genotype, pulmonary function (FEV1), Pseudomonas aeruginosa colonization, and clinical status.
Main Results:
- Mean serum levels of interleukin-8 and monocyte chemoattractant protein-1 were significantly higher in Group A compared to Group B (P < 0.01).
- Interleukin-8 levels showed an inverse correlation with forced expiratory volume in 1 second (FEV1) (r = -0.37, P < 0.02).
- Pseudomonas aeruginosa colonization rates were higher in Group A (88%) than in Group B (40%) (P < 0.01).
Conclusions:
- Serum interleukin-8 levels are associated with more severe cystic fibrosis genotypes and reduced lung function.
- Elevated interleukin-8 may serve as an early indicator of pulmonary inflammation in cystic fibrosis patients.
- These findings support the potential use of interleukin-8 as a biomarker to guide anti-inflammatory treatment strategies.